[Immune prophylaxis of hepatitis B].
Jilg
W
W
Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Regensburg. Wolfgang.Jilg@klinik.uni-regensburg.de
Rink
C
C
Kallinowski
B
B
D019072:Antibiotic Prophylaxis / Q000379:methods; D032921:Consensus; D005858:Germany; D006509:Hepatitis B / Q000175:diagnosis* / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D010346:Patient Care Management / Q000379:methods* / Q000592:standards*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods* / Q000592:standards*; D055502:Secondary Prevention; D012720:Severity of Illness Index; D016896:Treatment Outcome